Explain How Suzetrigine Stacks Up for Acute Pain
The spotlight is on suzetrigine (Journavx), the first med in a new class of NON-opioid analgesics for acute pain in over 2 decades.
Suzetrigine is a selective sodium channel blocker...that prevents pain signals in the peripheral nervous system from reaching the brain.
It’s NOT a controlled substance...and it doesn’t have warnings about misuse, respiratory depression, etc.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote